GL1X · GenesisL1 explorer

Research workbench

Crystal structure of drosophila numb ptb domain and pon peptide complex

Analyse Crystal structure of drosophila numb ptb domain and pon peptide complex in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5YI7
Type
protein
Length
293 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein numb; Pon peptide from partner of numb
UniProt
P16554, Q9W4I7
Pockets
1 · best druggability 0.39

Structure

x-ray diffraction · 3 distinct chains · 29% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein numbprotein12830% helix, 42% strandP16554
B, DPon peptide from partner of numbprotein170% helix, 12% strandQ9W4I7
CProtein numbprotein13132% helix, 41% strandP16554

Ligands and binding sites

  • GOL · Glycerol · additive · 2 copies · chains A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11290.390.7423empty

Interfaces

4 interfaces between chains.

  • C–D · 548 Ų buried · 9 hydrogen bonds · protein-protein
  • A–B · 544 Ų buried · 7 hydrogen bonds · protein-protein
  • A–C · 167 Ų buried · 1 hydrogen bond · protein-protein
  • A–D · 110 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 5YI7 · Crystal structure of drosophila Numb PTB domain and Pon peptide complex · the same entry in another collection · chain A against A, TM-score 1.00
  • P16554 · AlphaFold monomer V2.0 prediction for protein numb (P16554) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.